Prevalence and risk factors of antibiotic resistance for urinary tract infections in patients presenting to a Belgian tertiary care emergency department: testing the national guidelines against the local setting
In the studied Belgian ED setting, ceftriaxone seems slightly safer than ciprofloxacin, especially for recurrent UTI patients. However, overall, and especially in patients at risk for ESBL-producing bacteria, temocillin would be an even better choice in our setting. National microbiological data should be reviewed to support recommending temocillin as a first-line antibiotic in patients presenting with upper UTI.
Authors
- Eveline Van Honacker (ORCID: https://orcid.org/0000-0002-1617-5839)
- Johan Van Laethem (ORCID: https://orcid.org/0000-0002-2490-216X)
- Lisa Schmitz (ORCID: https://orcid.org/0000-0002-6903-4028)
- Sabine Allard
- Steven Pauwels (ORCID: https://orcid.org/0000-0003-0056-6795)
- Ives Hubloue (ORCID: https://orcid.org/0000-0002-4535-801X)
- Ingrid Wybo (ORCID: https://orcid.org/0000-0002-6217-1695)
- L. Yepiskoposyan
- A. Bouteille
Institutions
- Vrije Universiteit Brussel (BE)
- Maastricht University (NL)
- Mathys (Netherlands) (NL)
Publication Details
- Journal
- Acta Clinica Belgica
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1080/17843286.2024.2446684
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00